Literature DB >> 7044301

Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy.

C Herrera, M N Guentzel.   

Abstract

Persistent infection of the gastrointestinal tract of CFW mice with Candida albicans was produced by the oral-intragastric inoculation of 6-day-old infants. Other intraabdominal organs (liver, kidneys, and spleen) were usually free of the organism in survivors at 20 days of age. However, all survivors retained high levels of the organism in the stomach and intestinal tract at 30 days of age. The possible utility of these persisting C. albicans infections of the gastrointestinal tract for the study of the efficacy of short-term antifungal therapy was studied. Drug treatment was initiated for a 2-week period when the survivors were 15 to 19 days old. Some representative antifungal agents in current use (i.e., amphotericin B, 5-fluorocytosine, and miconazole) effected significant reductions in the numbers of C. albicans in homogenates of gastrointestinal organs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044301      PMCID: PMC181827          DOI: 10.1128/AAC.21.1.51

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans.

Authors:  P B Helstrom; E Balish
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

2.  Colonization of the intestinal tract of conventional mice with Candida albicans and treatment with antifungal agents.

Authors:  J R Turner; T F Butler; M E Johnson; R S Gordee
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge.

Authors:  L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

4.  Persistence and spread of Candida albicans after intragastric inoculation of infant mice.

Authors:  L H Field; L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

5.  Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

Authors:  M N Guentzel; C Herrera
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

  6 in total
  4 in total

1.  Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.

Authors:  Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Individual evolution of digestive tract colonization of holoxenic mice by Candida albicans.

Authors:  S Walbaum; L Dujardin
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

3.  Evaluation of a murine model of hepatic candidiasis.

Authors:  G T Cole; K T Lynn; K R Seshan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Colonization of congenitally athymic, gnotobiotic mice by Candida albicans.

Authors:  E Balish; M J Balish; C A Salkowski; K W Lee; K F Bartizal
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.